These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 11455193)

  • 1. Cardiovascular risk in obese and nonobese patients with type 2 diabetes in the West Indies.
    Ezenwaka CE; Offiah NV
    J Biomed Sci; 2001; 8(4):314-20. PubMed ID: 11455193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in glycemic control and cardiovascular risk in primary care patients with type 2 diabetes in West Indies.
    Ezenwaka CE; Offiah NV
    Clin Exp Med; 2001 Jun; 1(2):91-8. PubMed ID: 11699733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classical cardiovascular risk factors in Trinidadian patients with type 2 diabetes mellitus are not influenced by the level of plasma glycaemia.
    Ezenwaka CE; Offiah NV
    West Indian Med J; 2001 Dec; 50(4):288-93. PubMed ID: 11993019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in cardiovascular disease risk factors in elderly and younger patients with type 2 diabetes in the West Indies.
    Ezenwaka CE; Offiah NV
    Singapore Med J; 2002 Oct; 43(10):497-503. PubMed ID: 12587703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abdominal obesity in type 2 diabetic patients visiting primary healthcare clinics in Trinidad, West Indies.
    Ezenwaka CE; Offiah NV
    Scand J Prim Health Care; 2002 Sep; 20(3):177-82. PubMed ID: 12389757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clustering of cardiovascular disease risk factors among obese schoolchildren: the Taipei Children Heart Study.
    Chu NF; Rimm EB; Wang DJ; Liou HS; Shieh SM
    Am J Clin Nutr; 1998 Jun; 67(6):1141-6. PubMed ID: 9625086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.
    Quispe R; Martin SS; Jones SR
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):150-6. PubMed ID: 26863278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).
    Ito H; Harano Y; Suzuki M; Hattori Y; Takeuchi M; Inada H; Inoue J; Kawamori R; Murase T; Ouchi Y; Umeda F; Nawata H; Orimo H
    Diabetes; 1996 Jul; 45 Suppl 3():S19-23. PubMed ID: 8674883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of cardiometabolic profile in obese diabetic patients after bariatric surgery: changes in cardiovascular risk.
    Pujante P; Hellín MD; Fornovi A; Martínez Camblor P; Ferrer M; García-Zafra V; Hernández AM; Frutos MD; Luján-Monpeán J; Tébar J
    Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):812-8. PubMed ID: 24773862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of cardiovascular disease in newly diagnosed type 2 diabetic patients in a primary health care center in Trinidad.
    Ezenwaka CE; Davis G
    Diabetes Res Clin Pract; 2000 Oct; 50(2):137-45. PubMed ID: 10960724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex- and BMI-related differences in risk factors for coronary artery disease in patients with type 2 diabetes mellitus.
    Bo S; Gentile L; Cavallo-Perin P; Vineis P; Ghia V
    Acta Diabetol; 1999 Sep; 36(3):147-53. PubMed ID: 10664319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abdominal obesity is associated with ineffective control of cardiovascular risk factors in primary care in France.
    Dallongeville J; Bringer J; Bruckert E; Charbonnel B; Dievart F; Komajda M; Pouchain D; Amouyel P
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):606-11. PubMed ID: 19019717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology.
    Franzini L; Ardigò D; Cavalot F; Miccoli R; Rivellese AA; Trovati M; Zavaroni I; Vaccaro O
    Nutr Metab Cardiovasc Dis; 2013 Mar; 23(3):235-41. PubMed ID: 22397873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The metabolic syndrome in patients with type 1 diabetes mellitus. Associations with cardiovascular risk factors and cardiovascular morbidity].
    Reindel J; Zander E; Heinke P; Kohnert KD; Allwardt C; Kerner W
    Herz; 2004 Aug; 29(5):463-9. PubMed ID: 15340731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiorespiratory capacity is associated with favourable cardiovascular risk profile in patients with Type 2 diabetes.
    Kadoglou NP; Iliadis F; Angelopoulou N; Sailer N; Fotiadis G; Voliotis K; Vitta I; Liapis CD; Alevizos M
    J Diabetes Complications; 2009; 23(3):160-6. PubMed ID: 18413173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual dysfunction is frequent in premenopausal women with diabetes, obesity, and hypothyroidism, and correlates with markers of increased cardiovascular risk. A preliminary report.
    Veronelli A; Mauri C; Zecchini B; Peca MG; Turri O; Valitutti MT; Dall'Asta C; Pontiroli AE
    J Sex Med; 2009 Jun; 6(6):1561-1568. PubMed ID: 19453923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group.
    Reeder BA; Angel A; Ledoux M; Rabkin SW; Young TK; Sweet LE
    CMAJ; 1992 Jun; 146(11):2009-19. PubMed ID: 1596850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypertriglyceridemic waist phenotype and metabolic syndrome by differing criteria in type 2 diabetic patients and their relation to lipids and blood glucose control.
    Radenković SP; Kocić RD; Pešić MM; Dimić DN; Golubović MD; Radojković DB; Cirić VM
    Endokrynol Pol; 2011; 62(4):316-23. PubMed ID: 21879471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus.
    Hollander P
    Am J Med; 2007 Feb; 120(2 Suppl 1):S18-28; discussion S29-32. PubMed ID: 17296341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.